Artículos de revistas sobre el tema "Hematologic neoplasm"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Hematologic neoplasm".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Hoermann, Gregor. "Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease". Diagnostics 12, n.º 7 (2 de julio de 2022): 1613. http://dx.doi.org/10.3390/diagnostics12071613.
Texto completoShanmugam, Vignesh, Aric Parnes, Elizabeth A. Morgan y Annette S. Kim. "Clinical Utility of Routine Targeted Next-Generation Sequencing of Peripheral Blood in the Evaluation of Patients with Cytopenias". Blood 132, Supplement 1 (29 de noviembre de 2018): 3090. http://dx.doi.org/10.1182/blood-2018-99-117922.
Texto completoNguyen, Andy N. D., Jitakshi De, Jacqueline Nguyen, Anthony Padula y Zhenhong Qu. "A Teaching Database for Diagnosis of Hematologic Neoplasms Using Immunophenotyping by Flow Cytometry". Archives of Pathology & Laboratory Medicine 132, n.º 5 (1 de mayo de 2008): 829–37. http://dx.doi.org/10.5858/2008-132-829-atdfdo.
Texto completoFunari, Vincent, Wanlong Ma, Maya Thangavelu, Ivan De Dios y Maher Albitar. "Using Next Generation Sequencing of Peripheral Blood cfDNA As a Clinical Test in Screening for Hematologic Neoplasms". Blood 128, n.º 22 (2 de diciembre de 2016): 3176. http://dx.doi.org/10.1182/blood.v128.22.3176.3176.
Texto completoParamonov, V. V. y I. S. Diagil. "Cumulative incidence of hematological neoplasms and dynamic of this in different regions of the Cherkasy oblast in 1980, 1989, 2001 and 2014 years". Клінічна та профілактична медицина 2, n.º 8 (22 de agosto de 2019): 69–76. http://dx.doi.org/10.31612/2616-4868.2(8).2019.08.
Texto completoSumoza, Luis David, Marina Messinger, Patricia Sumoza, Roxana Aguirre, Poola Harsha y Dayra Avila. "Concurrent Tumors in Patients with Hematologic Malignancies". Blood 124, n.º 21 (6 de diciembre de 2014): 5997. http://dx.doi.org/10.1182/blood.v124.21.5997.5997.
Texto completoGaulin, Charles, Katalin Kelemen y Cecilia Arana Yi. "Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm". Life 12, n.º 8 (28 de julio de 2022): 1135. http://dx.doi.org/10.3390/life12081135.
Texto completoXu, Y. y P. H. Wiernik. "Systemic lupus erythematosus and B-cell hematologic neoplasm". Lupus 10, n.º 12 (diciembre de 2001): 841–50. http://dx.doi.org/10.1191/096120301701548481.
Texto completoLabrador, Jorge, Covadonga Garcia Diaz, Beatriz Cuevas, Rodolfo Alvarez, Maria Victoria Cuevas, Gerardo Hermida, Tomas Jose Gonzalez-Lopez y Pilar de Vicente. "Incidence of Second Malignancies in the History of Chronic Lymphocytic Leukemia". Blood 138, Supplement 1 (5 de noviembre de 2021): 4693. http://dx.doi.org/10.1182/blood-2021-148016.
Texto completoOzhand, Ali, Thomas M. Mack, Sophia S. Wang, Ann S. Hamilton, Amie E. Hwang, Dennis K. Deapen, Bharat N. Nathwani y Wendy Cozen. "Heritability of Hematologic Neoplasms in Twins: An Update". Blood 120, n.º 21 (16 de noviembre de 2012): 3636. http://dx.doi.org/10.1182/blood.v120.21.3636.3636.
Texto completoLim, Tristan L., David B. Lieberman, Adam R. Davis, Ryan Hausler, Ashkan Bigdeli, Yimei Li, Jacquelyn Powers et al. "Germline POT1 Variants Can Predispose to a Variety of Hematologic Neoplasms". Blood 136, Supplement 1 (5 de noviembre de 2020): 2–4. http://dx.doi.org/10.1182/blood-2020-134160.
Texto completoHoermann, Gregor, Georg Greiner, Andrea Griesmacher y Peter Valent. "Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology". Journal of Personalized Medicine 10, n.º 3 (20 de agosto de 2020): 94. http://dx.doi.org/10.3390/jpm10030094.
Texto completoEconomopoulou, Panagiota, Athena Chrysikopoulou, Kalliroi Goula, Ilectra Papiri, Amanda Psyrri, Ioannis Kotsantis, Nikolaos Arkadopoulos y Nikolaos V. Michalopoulos. "Breast Metastasis from Neuroendocrine Carcinoma of the Lung: A Case Report and Review of the Literature". Case Reports in Oncology 13, n.º 3 (16 de octubre de 2020): 1281–84. http://dx.doi.org/10.1159/000510936.
Texto completoStojanoski, Zlate, Anzelika Karadzova-Stojanoska, Aleksandra Pivkova-Veljanovska, Sonja Genadieva-Stavrik, Lazar Cadievski, Martin Ivanovski, Oliver Karanfilski, Lidija Cevreska y Borce Georgievski. "Treatment of Severe Autoimmune Diseases with Autologous Hematopoietic Stem Cell Transplantation". Macedonian Medical Review 71, n.º 1 (1 de enero de 2017): 10–14. http://dx.doi.org/10.1515/mmr-2017-0003.
Texto completoNaoe, Tomoki. "1) Chemical and Molecular-targeted Therapy of Hematologic Neoplasm". Nihon Naika Gakkai Zasshi 97, n.º 9 (2008): 2093–97. http://dx.doi.org/10.2169/naika.97.2093.
Texto completoNaoe, Tomoki. "1) Chemical and Molecular-targeted Therapy of Hematologic Neoplasm". Nihon Naika Gakkai Zasshi 97, Suppl (2008): 85a. http://dx.doi.org/10.2169/naika.97.85a.
Texto completoSepkowitz, Kent A. "Treatment of Patients with Hematologic Neoplasm, Fever, and Neutropenia". Clinical Infectious Diseases 40, Supplement_4 (1 de abril de 2005): S253—S256. http://dx.doi.org/10.1086/427330.
Texto completoAsou, N., T. Hattori, M. Matsuoka, F. Kawano y K. Takatsuki. "Rearrangements of T-cell antigen receptor delta chain gene in hematologic neoplasms". Blood 74, n.º 8 (1 de diciembre de 1989): 2707–12. http://dx.doi.org/10.1182/blood.v74.8.2707.2707.
Texto completoAsou, N., T. Hattori, M. Matsuoka, F. Kawano y K. Takatsuki. "Rearrangements of T-cell antigen receptor delta chain gene in hematologic neoplasms". Blood 74, n.º 8 (1 de diciembre de 1989): 2707–12. http://dx.doi.org/10.1182/blood.v74.8.2707.bloodjournal7482707.
Texto completoDunlap, Quinn A., Kristine E. Day, Samuel G. Borak y Bradford A. Woodworth. "Pathology Quiz Case: Plasmacytoid Dendritic Cell Neoplasm". Allergy & Rhinology 5, n.º 1 (enero de 2014): ar.2014.5.0085. http://dx.doi.org/10.2500/ar.2014.5.0085.
Texto completoSteensma, David P. "New challenges in evaluating anemia in older persons in the era of molecular testing". Hematology 2016, n.º 1 (2 de diciembre de 2016): 67–73. http://dx.doi.org/10.1182/asheducation-2016.1.67.
Texto completoNaiyer, N. y H. Lin. "Diagnostic utility of flow cytometric immunophenotyping in cerebrospinal fluid specimen". American Journal of Clinical Pathology 156, Supplement_1 (1 de octubre de 2021): S121. http://dx.doi.org/10.1093/ajcp/aqab191.258.
Texto completoSonneveld, Pieter, Johannes Abels, Karl Heinz Kurth y Anne Hagemeyer. "Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma". Cancer 65, n.º 1 (1 de enero de 1990): 23–25. http://dx.doi.org/10.1002/1097-0142(19900101)65:1<23::aid-cncr2820650107>3.0.co;2-q.
Texto completoTegg, Elizabeth M., Russell J. Thomson, Jim M. Stankovich, Annette Banks, Katherine A. Marsden, Ray M. Lowenthal, Simon J. Foote y Joanne L. Dickinson. "Anticipation in familial hematologic malignancies". Blood 117, n.º 4 (27 de enero de 2011): 1308–10. http://dx.doi.org/10.1182/blood-2010-07-296475.
Texto completoPak, Daniel M. y Maria S. Tretiakova. "An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor". Case Reports in Pathology 2019 (7 de octubre de 2019): 1–4. http://dx.doi.org/10.1155/2019/9196167.
Texto completoIliakis, Theodoros, Niki Rougkala, Panagiotis T. Diamantopoulos, Vasiliki Papadopoulou, Fani Kalala, Konstantinos Zervakis, Nefeli Giannakopoulou et al. "An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia". Case Reports in Medicine 2014 (2014): 1–5. http://dx.doi.org/10.1155/2014/526129.
Texto completoKutler, David I., Bhuvanesh Singh, Jaya Satagopan, Sat Dev Batish, Marianne Berwick, Philip F. Giampietro, Helmut Hanenberg y Arleen D. Auerbach. "A 20-year perspective on the International Fanconi Anemia Registry (IFAR)". Blood 101, n.º 4 (15 de febrero de 2003): 1249–56. http://dx.doi.org/10.1182/blood-2002-07-2170.
Texto completoLoring, Lisa A., David M. Panicek y Martin S. Karpeh. "Portal System Thrombosis After Splenectomy for Neoplasm or Chronic Hematologic Disorder". Journal of Computer Assisted Tomography 22, n.º 6 (noviembre de 1998): 856–60. http://dx.doi.org/10.1097/00004728-199811000-00003.
Texto completoTefferi, Ayalew, Sahrish Shah, Terra L. Lasho, Mrinal M. Patnaik, Kaaren K. Reichard, Curtis A. Hanson, Rhett P. Ketterling y Animesh Pardanani. "Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm". American Journal of Hematology 93, n.º 12 (17 de octubre de 2018): E383—E386. http://dx.doi.org/10.1002/ajh.25269.
Texto completoKasbekar, Monica, Valentina Nardi, Paola Dal Cin, Andrew M. Brunner, Meghan Burke, Yi-Bin Chen, Christine Connolly et al. "Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia". Blood Advances 4, n.º 13 (10 de julio de 2020): 3136–40. http://dx.doi.org/10.1182/bloodadvances.2020002308.
Texto completoLadetto, Marco, Sonia Vallet, Andreas Trojan, Maria Dell'Aquila, Luigia Monitillo, Rosalba Rosato, Loredana Santo et al. "Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome". Blood 105, n.º 12 (15 de junio de 2005): 4784–91. http://dx.doi.org/10.1182/blood-2004-11-4201.
Texto completoTavernier, Emmanuelle, Stephane de Botton, Nathalie Dhedin, Claude-Eric Bulabois, Oumedaly Reman, Norbert Vey, Frederic Garban et al. "Secondary or Concomitant Neoplasms among Adults Diagnosed with Acute Lymphoblastic Leukemia (ALL) and Treated According to the LALA-87 and LALA-94 Trials." Blood 106, n.º 11 (16 de noviembre de 2005): 1826. http://dx.doi.org/10.1182/blood.v106.11.1826.1826.
Texto completoFrederiksen, Henrik, Dóra Körmendiné Farkas, Christian Fynbo Christiansen, Hans Carl Hasselbalch y Henrik Toft Sørensen. "Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study". Blood 118, n.º 25 (15 de diciembre de 2011): 6515–20. http://dx.doi.org/10.1182/blood-2011-04-348755.
Texto completoTaylor, Justin, Mark Donoghue, Raajit K. Rampal, Roni Tamari, Martin S. Tallman, Darren R. Feldman, Barry S. Taylor y Omar I. Abdel-Wahab. "Hematologic Malignancies Arising in Patients with Germ Cell Tumors: Secondary Somatic Differentiation of Hematopoietic Malignancies from Germ Cell Precursors". Blood 132, Supplement 1 (29 de noviembre de 2018): 87. http://dx.doi.org/10.1182/blood-2018-99-111976.
Texto completoValiev, T. T., G. Z. Seregin, I. N. Serebryakova, O. A. Chernyshova, N. A. Kupryshina, A. D. Palladina, E. N. Sholokhova et al. "Blastic plasmacytoid dendritic cell neoplasm". Pediatric Hematology/Oncology and Immunopathology 18, n.º 4 (31 de diciembre de 2019): 79–89. http://dx.doi.org/10.24287/1726-1708-2019-18-4-79-89.
Texto completoEl Achi, Hanadi, Edouard Dupont, Shilpa Paul y Joseph D. Khoury. "CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies". Cancers 12, n.º 11 (23 de octubre de 2020): 3087. http://dx.doi.org/10.3390/cancers12113087.
Texto completoHanamornroongruang, Suchanan, Chanon Neungton y Malee Warnnissorn. "Extramedullary Hematopoiesis in the Uterine Cervix Associated with Tissue Repair". Case Reports in Obstetrics and Gynecology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/626130.
Texto completoHo, Caleb, Yanming Zhang, Umut Aypar, Mariko Yabe, Filiz Sen, Maria E. Arcila, Ahmet Dogan y Kseniya Petrova-Drus. "Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin". Blood 132, Supplement 1 (29 de noviembre de 2018): 3077. http://dx.doi.org/10.1182/blood-2018-99-115698.
Texto completoTang, Mengxiang, Jason Zhu, Wenchang Zhang y Oliver Crespo. "An automated data analysis strategy to identify and classify hematologic neoplasms (HEM3P.287)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 51.16. http://dx.doi.org/10.4049/jimmunol.192.supp.51.16.
Texto completoLi, Peng, Shobi Venkatachalam, Daniela Ospina Cordona, Lorena Wilson, Tibor Kovacsovics, Karen A. Moser, Rodney R. Miles, David B. Beck, Tracy George y Srinivas K. Tantravahi. "A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm". Blood Advances 6, n.º 2 (13 de enero de 2022): 405–9. http://dx.doi.org/10.1182/bloodadvances.2021005243.
Texto completoShomali, William y Jason Gotlib. "Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors". International Journal of Molecular Sciences 22, n.º 6 (15 de marzo de 2021): 2983. http://dx.doi.org/10.3390/ijms22062983.
Texto completoLee, Jiwon, Da Seul Jeong, Hyunji Jeon, Jin Hee Kim y Dong Yeon Kim. "Factors Affecting Intensive Care Unit Nurses’ Care Burden of Patients with Hematologic Neoplasm". Asian Oncology Nursing 22, n.º 4 (2022): 235. http://dx.doi.org/10.5388/aon.2022.22.4.235.
Texto completoWang, Xiaoyun. "Analysis of Humanistic Nursing Care in Regulating the Emotion, Satisfaction, and Sleep Quality of Inpatients with Hematologic Neoplasms". Proceedings of Anticancer Research 6, n.º 5 (9 de septiembre de 2022): 26–31. http://dx.doi.org/10.26689/par.v6i5.4288.
Texto completoWalz, Christoph, Philipp Erben, Michael Ritter, Adrian Bloor, Georgia Metzgeroth, Nick Telford, Claudia Haferlach et al. "Response of ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3". Blood 118, n.º 8 (25 de agosto de 2011): 2239–42. http://dx.doi.org/10.1182/blood-2011-03-343426.
Texto completoWong, Hannah H. y Jun Wang. "Merkel Cell Carcinoma". Archives of Pathology & Laboratory Medicine 134, n.º 11 (1 de noviembre de 2010): 1711–16. http://dx.doi.org/10.5858/2009-0165-rsr2.1.
Texto completoLaredo, Viviana, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo y Fernando Gomollón. "Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management". Cancers 15, n.º 3 (31 de enero de 2023): 871. http://dx.doi.org/10.3390/cancers15030871.
Texto completoVerma, Dushyant, Hagop Kantarjian, Sara S. Strom, Mary Beth Rios, Elias Jabbour, Alfonso Quintas-Cardama, Srdan Verstovsek, Farhad Ravandi, Susan O'Brien y Jorge Cortes. "Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies". Blood 118, n.º 16 (20 de octubre de 2011): 4353–58. http://dx.doi.org/10.1182/blood-2011-06-362889.
Texto completoChen, Ing, Jia-Bin Liao, Jung-Chia Lin, Pin-Pen Hsieh y Ming-Yun Hsieh. "Mast Cell Sarcoma of the Retroperitoneum With Concurrent Systemic Mastocytosis and an Undisclosed Associated Hematologic Neoplasm: A Case Report". Clinical Pathology 15 (enero de 2022): 2632010X2211235. http://dx.doi.org/10.1177/2632010x221123539.
Texto completoLin, Wen-Ying, Hsin-Hui Wang, Yi-Wei Chen, Chun-Fu Lin, Hueng-Chuen Fan y Yi-Yen Lee. "Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies". International Journal of Molecular Sciences 21, n.º 22 (17 de noviembre de 2020): 8655. http://dx.doi.org/10.3390/ijms21228655.
Texto completoReszka, Edyta, Ewa Jabłońska, Edyta Wieczorek, Peter Valent, Michel Arock, Gunnar Nilsson, Bogusław Nedoszytko y Marek Niedoszytko. "Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis". International Journal of Molecular Sciences 22, n.º 6 (15 de marzo de 2021): 2964. http://dx.doi.org/10.3390/ijms22062964.
Texto completo